Search Results - "Oikonen, V"

Refine Results
  1. 1

    Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease by KEMPPAINEN, N. M, AALTO, S, PARKKOLA, R, RINNE, J. O, WILSON, I. A, NAGREN, K, HELIN, S, BRÜCK, A, OIKONEN, V, KAILAJÄRVI, M, SCHEININ, M, VIITANEN, M

    Published in Neurology (14-11-2006)
    “…PET studies with N-methyl-[(11)C]2-(4':-methylaminophenyl)-6-hydroxybenzothiazole ([(11)C]PIB) have revealed an increased tracer uptake in several brain…”
    Get full text
    Journal Article
  2. 2

    PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment by KEMPPAINEN, N. M, AALTO, S, PARKKOLA, R, RINNE, J. O, WILSON, I. A, NAGREN, K, HELIN, S, BRÜCK, A, OIKONEN, V, KAILAJÄRVI, M, SCHEININ, M, VIITANEN, M

    Published in Neurology (08-05-2007)
    “…Patients with mild cognitive impairment (MCI) have increased risk to develop Alzheimer disease (AD). In AD increased brain amyloid burden has been demonstrated…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Cholinergic dysfunction after traumatic brain injury: Preliminary findings from a PET study by OSTBERG, A, VIRTA, J, RINNE, J. O, OIKONEN, V, LUOTO, P, NAGREN, K, ARPONEN, E, TENOVUO, O

    Published in Neurology (22-03-2011)
    “…There is evidence that the cholinergic system is frequently involved in the cognitive consequences of traumatic brain injury (TBI). We studied whether the…”
    Get full text
    Journal Article
  5. 5

    Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer’s disease by Rinne, J O, Kaasinen, V, Järvenpää, T, Någren, K, Roivainen, A, Yu, M, Oikonen, V, Kurki, T

    “…Objective: Brain acetylcholinesterase activity was determined in healthy controls and in patients with mild cognitive impairment and early Alzheimer’s disease…”
    Get full text
    Journal Article
  6. 6

    Kinetic modeling of [(18)F]FDG in skeletal muscle by PET: a four-compartment five-rate-constant model by Bertoldo, A, Peltoniemi, P, Oikonen, V, Knuuti, J, Nuutila, P, Cobelli, C

    “…Various modeling strategies have been developed to convert regional [(18)F]fluorodeoxyglucose ([(18)F]FDG) concentration measured by positron emission…”
    Get more information
    Journal Article
  7. 7

    Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease by KAASINEN, V, NAGREN, K, HIETALA, J, OIKONEN, V, VILKMAN, H, FARDE, L, HALLDIN, C, RINNE, J. O

    Published in Neurology (11-04-2000)
    “…To investigate whether dopamine D2 and D3 receptor subtypes (D2/3Rs) outside the caudate-putamen are affected in PD. Alterations in striatal D2-like dopamine…”
    Get full text
    Journal Article
  8. 8

    Non-esterified fatty acids impair insulin-mediated glucose uptake and disposition in the liver by IOZZO, P, LAUTAMAKI, R, GEISLER, F, VIRTANEN, K. A, OIKONEN, V, HAAPARANTA, M, YKI-JARVINEN, H, FERRANNINI, E, KNUUTI, J, NUUTILA, P

    Published in Diabetologia (01-07-2004)
    “…We investigated the effect of elevated circulating NEFA on insulin-mediated hepatic glucose uptake (HGU) and whole-body glucose disposal (M) in eight healthy…”
    Get full text
    Journal Article
  9. 9

    Exercise Restores Skeletal Muscle Glucose Delivery But Not Insulin-Mediated Glucose Transport and Phosphorylation in Obese Subjects by Slimani, L., Oikonen, V., Hällsten, K., Savisto, N., Knuuti, J., Nuutila, P., Iozzo, P.

    “…Context/Objective: Insulin resistance in obese subjects results in the impaired disposal of glucose by skeletal muscle. The current study examined the effects…”
    Get full text
    Journal Article
  10. 10

    Measurement of serotonin 5-HT1A receptor binding using positron emission tomography and [carbonyl-11C]WAY-100635—considerations on the validity of cerebellum as a reference region by Hirvonen, Jussi, Kajander, J., Allonen, T., Oikonen, V., Någren, K., Hietala, J.

    Published in NeuroImage (Orlando, Fla.) (2006)
    “…Background: The selective and potent radioligand [carbonyl-11C]WAY-100635 provides a useful tool for the in vivo measurement of 5-HT1A receptor binding with…”
    Get full text
    Journal Article
  11. 11

    [11C]Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy: Correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology by LAMUSUO, S, PITKÄNEN, A, VAPALAHTI, M, VAINIO, P, RINNE, J. O, JUTILA, L, YLINEN, A, PARTANEN, K, KÄLVIÄINEN, R, RUOTTINEN, H.-M, OIKONEN, V, NAGREN, K, LEHIKOINEN, P

    Published in Neurology (27-06-2000)
    “…To detect reduced [11C]flumazenil in patients with temporal lobe epilepsy (TLE) and to relate binding to histopathology. The authors studied 16 patients who…”
    Get full text
    Journal Article
  12. 12

    Striatal uptake of a novel PET ligand, [18F]β-CFT, is reduced in early Parkinson's disease by Rinne, J.O., Bergman, J., Ruottinen, H., Haaparanta, M., Eronen, E., Oikonen, V., Sonninen, P., Solin, O.

    Published in Synapse (New York, N.Y.) (01-02-1999)
    “…[18F]β‐CFT is a novel PET ligand for dopamine reuptake sites. In this study, [18F]β‐CFT uptake was studied in nine patients with early Parkinson's disease (PD)…”
    Get full text
    Journal Article
  13. 13

    [18F]fluorodopa PET shows striatal dopaminergic dysfunction in juvenile neuronal ceroid lipofuscinosis by Ruottinen, H M, Rinne, J O, Haaparanta, M, Solin, O, Bergman, J, Oikonen, V J, Järvelä, I, Santavuori, P

    “…OBJECTIVES: To investigate whether nigrostriatal dopaminergic hypofunction is related to the extrapyramidal symptoms in patients with juvenile neuronal ceroid…”
    Get full text
    Journal Article
  14. 14

    Different Metabolic Responses of Human Brown Adipose Tissue to Activation by Cold and Insulin by Orava, Janne, Nuutila, Pirjo, Lidell, Martin E., Oikonen, Vesa, Noponen, Tommi, Viljanen, Tapio, Scheinin, Mika, Taittonen, Markku, Niemi, Tarja, Enerbäck, Sven, Virtanen, Kirsi A.

    Published in Cell metabolism (03-08-2011)
    “…We investigated the metabolism of human brown adipose tissue (BAT) in healthy subjects by determining its cold-induced and insulin-stimulated glucose uptake…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    PET studies on brain monoamine transporters with carbon-11-β-CIT in Parkinson's disease by LAIHINEN, A. O, RINNE, J. O, NAGREN, K. A, LEHIKOINEN, P. K, OIKONEN, V. J, RUOTSALAINEN, U. H, RUOTTINEN, H. M, RINNE, U. K

    Published in The Journal of nuclear medicine (1978) (01-07-1995)
    “…The cocaine analog 2 beta-carbomethoxy-3 beta-[4-iodophenyl]tropane (beta-CIT) labeled with 11C was used to study dopamine reuptake sites with PET. Three…”
    Get full text
    Journal Article
  18. 18

    Impact of metabolic substrate modification on myocardial efficiency in a rat model of obesity and diabetes by Virta, J, M U Silvola, J, Kiugel, M, Liljenback, H, Berglund, L M, Garcia-Vaz, E, Dutius Andersson, A M, Zetterqvist, A, Oikonen, V, Jauhianen, M, Knuuti, J, Nuutila, P, Roivainen, A, F Gomez, M, Saraste, A

    Published in European Heart Journal, Supplement (03-10-2022)
    “…Abstract Background Congenic leptin receptor deficient rat generated by introgression of the Koletsky leptin receptor mutation into BioBreeding Diabetes…”
    Get full text
    Journal Article Conference Proceeding
  19. 19
  20. 20